Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Universite Laval patents IL-6 expression inhibitors

Jan. 8, 2019

Galapagos initiates phase I trial with GLPG-3312

Jan. 7, 2019

Resolvin receptor analogues limit inflammation

Dec. 18, 2018

Anti-inflammatory compositions presented by House Wellness Foods, House Foods Group

Nov. 29, 2018

New anti-inflammation target has similarities, and differences, to PARP

Nov. 23, 2018

New path to RAS activation discovered

Nov. 23, 2018

The point of disorder

Nov. 21, 2018

ILDONG Pharmaceutical discovers farnesoid X receptor agonists

Nov. 2, 2018

Eiger's phase II study of ubenimex in lower leg lymphedema does not meet endpoints

Oct. 17, 2018

SHIP2 is key in FGF signaling and necessary for the maintenance of FGF-mediated ERK activation

Oct. 15, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...